Hedge Fund - Biotechnology Value Fund / BVF Inc
Revolution Medicines Inc. (RVMD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $182,884,769 | 6.19% | 4,181,179 | $50.47 |
| 2 | 2024 - Q3 (2024-09-30) | $157,755,054 | 4.61% | 3,478,612 | $43.54 |
| 3 | 2024 - Q2 (2024-06-30) | $232,130,838 | 6.5% | 5,981,212 | $37.38 |
| 4 | 2024 - Q1 (2024-03-31) | $192,774,463 | 5.29% | 5,981,212 | $29.64 |
| 5 | 2023 - Q4 (2023-12-31) | $171,541,160 | 4.29% | 5,981,212 | $24.03 |
| 6 | 2023 - Q3 (2023-09-30) | $110,199,948 | 2.97% | 3,981,212 | $29.66 |
| 7 | 2023 - Q2 (2023-06-30) | $167,336,979 | 4.66% | 6,255,588 | $24.54 |
| 8 | 2023 - Q1 (2023-03-31) | $107,338,036 | 3.92% | 4,955,588 | $24.62 |
| 9 | 2022 - Q4 (2022-12-31) | $77,548,106 | 3.27% | 3,255,588 | $21.26 |
| 10 | 2022 - Q3 (2022-09-30) | $64,200,000 | 2.65% | 3,255,588 | $21.98 |
| 11 | 2022 - Q2 (2022-06-30) | $43,961,000 | 2.12% | 2,255,588 | $19.47 |
| 12 | 2022 - Q1 (2022-03-31) | $46,187,000 | 1.84% | 1,810,549 | $21.77 |
| 13 | 2021 - Q4 (2021-12-31) | $45,572,000 | 1.65% | 1,810,549 | $28.18 |
| 14 | 2021 - Q3 (2021-09-30) | $68,364,000 | 2.66% | 2,485,049 | $29.11 |
| 15 | 2021 - Q2 (2021-06-30) | $78,875,000 | 2.95% | 2,485,049 | $34.90 |
| 16 | 2021 - Q1 (2021-03-31) | $135,027,000 | 5.06% | 2,943,049 | $44.84 |
| 17 | 2020 - Q4 (2020-12-31) | $109,587,000 | 4.31% | 2,768,049 | $39.54 |
| 18 | 2020 - Q3 (2020-09-30) | $73,117,000 | 3.98% | 2,101,049 | $27.70 |
| 19 | 2020 - Q2 (2020-06-30) | $25,202,000 | 1.55% | 798,286 | $31.44 |
| 20 | 2020 - Q1 (2020-03-31) | $30,632,000 | 2.85% | 1,398,070 | $27.68 |
The displayed share prices are average quarterly stock market prices.